step 7 semaglutide Efficacy and safety of once weekly 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial Efficacy and safety of once

S.DavisL

doi: 10.1210/clinem/dgac662

You can not be treated with semaglutide or Tirzepatide if you have: Medullary thyroid cancer Multiple endocrine neoplasia Type 1 diabetics Type 2 diabetics already taking a GLP-1 medication History of pancreatitis Chronic kidney disease (unless cleared by nephrologist) Nursing, pregnant, or trying to get pregnant Short moments of nausea, Constipation or diarrhea Fatigue Takes away desire for alcohol Yes, unlike vaccines or many other shots you may think of, this injection is done with a tiny needle that only goes under the skin, not into muscle

The Danish pharmaceutical giant faced pushback once again Thursday, as shareholders urged the board for clearer and tactically sound trials and targets in a bid to provoke less dramatic share price moves